A randomised controlled trial, economic evaluation and qualitative study of supervised consumption in patients managed with opiate maintenance treatment (the Super-C study)

Hertfordshire Partnership NHS Foundation Trust (UK)0 sites256 target enrollmentFebruary 5, 2008

Overview

No summary available.

Registry

who.int

Start Date

February 5, 2008

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Sex

All

Sponsor

Hertfordshire Partnership NHS Foundation Trust (UK)

•1\. Confirmed symptoms of opioid dependency (including toxicological investigations)
•2\. Electing for maintenance treatment (as opposed to other forms of management, e.g., detoxification) with either methadone or buprenorphine
•3\. Aged 16 years or older, either sex

•1\. Chronic injectors refusing oral therapy
•2\. Under 16 years
•3\. Hypersensitivity to both buprenorphine and methadone
•4\. Treatment with suboxone (as this is not routinely supervised)
•5\. Severe medical condition making treatment hazardous in the opinion of the treating physician
•6\. Incapacity to give informed consent
•7\. Maintenance treatment during last four weeks
•8\. Those patients deemed to definitely require supervised consumption at discretion of the treating physician (such as homeless, those with a drug\-using partner not in treatment)
•9\. Those patients where supervised consumption of their agreed treatment can not be provided for reasons of geographical placement (e.g. no provision of supervised consumption in the local pharmacy)